ClinVar Miner

Submissions for variant NM_003119.4(SPG7):c.1939del

dbSNP: rs1567934181
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001009230 SCV001169050 pathogenic not provided 2019-01-22 criteria provided, single submitter clinical testing The c.1939delG variant causes a frameshift starting with codon Alanine 647, changes this amino acid to a Histidine residue, and creates a premature Stop codon at position 5 of the new reading frame, denoted p.Ala647HisfsX5. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.1939delG variant is not observed in large population cohorts (Lek et al., 2016). Although the c.1939delG has not been reported previously to our knowledge, other loss-of-function variants in the SPG7 gene have been reported in the Human Gene Mutation Database in association with SPG7-related disorders (Stenson et al., 2014).
Labcorp Genetics (formerly Invitae), Labcorp RCV001860602 SCV002239054 pathogenic Hereditary spastic paraplegia 7 2021-06-24 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Ala647Hisfs*5) in the SPG7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG7 are known to be pathogenic (PMID: 21623769, 22964162). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SPG7-related conditions. ClinVar contains an entry for this variant (Variation ID: 817991). For these reasons, this variant has been classified as Pathogenic.
3billion RCV001860602 SCV002572562 pathogenic Hereditary spastic paraplegia 7 2022-09-01 criteria provided, single submitter clinical testing The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). This variant on the canonical splice site is predicted to alter splicing, resulting in a loss or disruption of normal protein function. Multiple pathogenic loss-of-function variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000817991). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.